Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kite Pharma

Explore full profile

Immune-based therapies to treat cancer indications

Santa Monica, United StatesFounded 2009Biotech & Life Sciences
Valuation $12B Market cap · 2026
Revenue $20M Latest reported FY

At a glance

Status
Listed
Founded
2009
Headquarters
Santa Monica, United States
Listing
IPO 2014
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tier

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Two River
  • Riverbank Capital Securities
  • Lee Linden
  • Alta Partners

Series B and later5 investors entered at this stage

  • National Cancer Institute (NCI)
  • Arie Belldegrun
  • Weizmann Institute of Science
  • University of California
  • Los Angeles

Talent

Book a demo to see the people
Employees mapped 4,029 incl. 16 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
33 countries with
team presence
🇺🇸 United States66.6%
🇳🇱 Netherlands24.4%
🇬🇧 United Kingdom2.4%
🇪🇸 Spain0.9%
🇮🇪 Ireland0.9%
Top 5 of 33 shown
Web traffic by country
20K monthly visits
across markets
🇺🇸 United States60.5%
🇳🇱 Netherlands12.5%
🇬🇧 United Kingdom9.5%
🇮🇳 India6.5%
🇵🇭 Philippines4%
Top 5 markets shown

Patents

Estimated portfolio value
$199M

176 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Kite Pharma was the backer or acquirer, 2016–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

14 deals across Kite Pharma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Kite Pharma's portfolio, mapped.

        Stage
        Period
        14 of 14 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Kite Pharma on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Kite Pharma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles